10月10日，由red herring主办的“red herring asia top 100”高峰论坛在曼谷香格里拉完美落下帷幕，论坛汇聚了众多亚太区科技领域杰出的公司，优秀的企业ceo与创始人出席，基准医疗创始人兼ceo范建兵博士也受邀出席了会议。同时，在此次“red herring asia top 100”评选活动中，基准医疗凭借在癌症早筛早诊领域的技术实力与优势入围了“red herring top 100 asia”，这标志着基准医疗在癌症早筛早诊等领域的快速发展，已受到国际风险投资界的广泛关注。
“red herring asia top 100”评选以专业独立性和从不接受赞助而著称，《red herring》杂志被誉为高科技领域的投资风向标，发现了很多有价值的新兴公司，在此前“red herring top 100”的评选中，illumina、google、ebay和skype等知名创新企业都获此殊荣。基准医疗是国內首家将ctdna甲基化高通量测序技术用于肿瘤诊断的企业，致力于高通量测序的临床应用和研发、提供国际领先的精准医疗技术和产品，以自主研发国际前沿的下一代基因检测、临床诊断、精准医疗和医疗“大数据”产品为核心业务方向，打造包括癌症早期诊断在内的具有高度临床应用价值的系列产品及后续研发平台。公司由基因技术领域世界级人才领军，凭借核心成员在精准医疗领域的影响力，在行业中独树一帜。anchordx selected as a 2019 red herring october 10th, 2019, bangkok, thailand—today, red herring announced its top 100 asia award winners in recognition of the leading private companies from the region, celebrating these startups’ innovations and technologies across their respective industries. anchordx’s ceo, dr. fan jian-bing was invited to be one of the speakers and out of hundreds of companies and finalists, anchordx was acknowledged for its tech superiority and selected as a top 100 asia winner for the year.“we are excited to receive this award.” said dr. fan jian-bing. “cancer screening and early diagnosis is a worldwide trend. anchordx will strive to accelerate the development of our technology and products, and to eventually improve the patients' life quality.”red herring top 100 asia enlists outstanding entrepreneurs and promising companies. it selects the award winners from approximately 1000 privately financed companies each year in the asia. since 1996, red herring haskept tabs on these up-and-comers. red herring editors were among the first to recognize that companies such as google, facebook, kakao, alibaba, twitter, rakuten, salesforce.com, xiaomi and youtube would change the way we live and work.“in 2019, selecting the top achievers was difficult as always,” said alex vieux, publisher and ceo of red herring. “the variety, depth, disruption and traction we saw from the early stage companies to those with significant scale made 2019 a great vintage to judge. the asia winners are representative of the amazing ecosystem that never ceases to astound, with new and experienced entrepreneurs continuing to pushthe barriers of innovation.“what has excited me most is to see so many people forging niches in high-tech and cutting edge sectors,” added vieux. “some of the technical wizardry and first-rate business models on show here atthe conference has been fantastic to learn about. we believe anchordx embodies the drive, skill and passion on which tech thrives. anchordx should be proud of its achievement: the competition was incredibly strong.”red herring’s editorial staff evaluated companies on both quantitative and qualitative criteria, such as financial performance, technological innovation and intellectual property, dna of the founders, business model, customer footprint and market penetration. this assessment of potential is complemented by a review of the track record and standing of startups relative to their sector peers, allowing red herring to see past the“buzz” and make the list a valuable instrument of discovery and advocacy for the most promising new business models in asia.red herring is a global media company, which unites the world’s best high technology innovators, venture investors and business decision makers in a variety of forums, including print, online and exclusive events worldwide. red herring provides an insider’sview and access to the global innovation economy, identifying new and innovative technology companies and entrepreneurs.anchordx is a biotechnology company based in china, focusing on developing leading ngs-based mdx products serving the greater china and global market. anchordx’s key business covers development, service and sales of ngs clinical diagnostics, ivd products, focusing on oncology and reproductive health.
基准医疗介绍
基准医疗致力于打造国际一流的高通量测序临床应用和研发平台，成为国际领先的精准医疗整体方案提供者。公司核心团队拥有20余年资深业界经验，涉足癌症基因组学、遗传学和生物信息学等领域。公司正面向精准医学，开发一系列具有自主知识产权和国际竞争力的临床基因检测产品。
提供国际领先的精准检测服务和产品
长按识别二维码
更多精彩敬请关注
2019-10-14
